Acquisition of Investment Securities and Valuation Losses
First written in FY2020-Q2. 5 of 24 entries say "Worsened", first in FY2021. Latest entry: FY2026.
Rentracks moved to the "Worse" side of this theme in 2026.
0 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「The amounts recorded on the consolidated balance sheet were ¥599.891 million at the end of the previous fiscal year and ¥1,308.346 million at the end of the current fiscal year, and an impairment loss on investment securities of ¥118.391 million was recognized as an extraordinary loss in the current fiscal year.」
While the balance of investment securities increased, the impairment loss expanded from ¥6.371 million in the previous fiscal year to ¥118.391 million. - FY2026-H1Acquisition of investment securities and recognition of impairment lossAnnual report
「Payments for the acquisition of investment securities (¥40.000 million)"Investment securities impairment loss 30,000」
During the interim period, ¥40.000 million was paid to acquire investment securities, and an impairment loss on investment securities of ¥30.000 million was recognized as an extraordinary loss. The balance of investment securities declined from ¥599.891 million at the end of the previous fiscal year to ¥590.906 million. - FY2025-H1Decrease in investment securities balance; no new impairment loss reportedAnnual report
「Investment securities 573,718 547,418」
The balance of investment securities declined from ¥573.718 million at the end of the previous fiscal year to ¥547.418 million at the end of the interim period. No impairment loss on investment securities was reported for the interim consolidated accounting period. - FY2024Increase in investment securities balance; impairment loss continuesAnnual report
「The Group actively made net investments, primarily overseas, from the previous fiscal year through the current fiscal year (amount recorded on the consolidated balance sheet: ¥497.823 million at the end of the previous fiscal year and ¥573.718 million at the end of the current fiscal year). The Group acquired investment securities at prices higher than net assets per share, anticipating excess earning power from synergies within the Group and returns from the future growth of the investee companies. However, an impairment loss on investment securities of ¥84.436 million was recognized as an extraordinary loss in the current fiscal year.」
The balance of investment securities increased from ¥497.823 million at the end of the previous fiscal year to ¥573.718 million, and an impairment loss on investment securities of ¥84.436 million was recognized. The disclosure describes both the increase in the investment balance and the continuation of the impairment loss. - FY2024-Q3Increase in Investment Securities BalanceAnnual report
「Investment securities increased by ¥140.273 million」
The balance of investment securities increased by ¥140.273 million, from ¥497.823 million at the end of the previous fiscal year to ¥638.096 million at the end of the third quarter. No impairment loss on investment securities was recognized for the cumulative third quarter. - FY2024-Q2Increase in Investment Securities BalanceAnnual report
「This was mainly due to increases of ¥1,272.421 million in cash and deposits, ¥185.963 million in the allowance for doubtful accounts and ¥104.060 million in investment securities, and decreases of ¥309.835 million in trade receivables, ¥3.001 million in merchandise and finished goods and ¥119.480 million in prepaid expenses.」
The balance of investment securities increased by ¥104.060 million, from ¥497.823 million at the end of the previous fiscal year to ¥601.883 million at the end of the second quarter. No impairment loss on investment securities was recognized for the cumulative quarter. - FY2024-Q1Increase in Investment Securities BalanceAnnual report
「Investment securities 497,823 569,843」
The balance of investment securities increased by ¥72.020 million, from ¥497.823 million at the end of the previous fiscal year to ¥569.843 million at the end of the first quarter. No impairment loss was reported for the quarter. - FY2023WorsenedAnnual report
「The Group actively made net investments, primarily overseas, from the previous fiscal year through the current fiscal year (amount recorded on the consolidated balance sheet: ¥516.063 million at the end of the previous fiscal year and ¥497.823 million at the end of the current fiscal year). The Group acquired investment securities at prices higher than net assets per share, anticipating excess earning power from synergies within the Group and returns from the future growth of the investee companies. However, an impairment loss on investment securities of ¥86.825 million was recognized as an extraordinary loss in the current fiscal year.」
The balance of investment securities declined to ¥497.823 million, while the impairment loss on investment securities increased from ¥59.109 million in the previous fiscal year to ¥86.825 million. - FY2023-Q3Quarterly increase in investment securities balanceAnnual report
「Investment securities 516,063 532,922」
The balance of investment securities increased by ¥16.859 million, from ¥516.063 million at the end of the previous consolidated fiscal year to ¥532.922 million at the end of the third quarter. The ¥49.325 million impairment loss on investment securities recognized for the cumulative second quarter continues to be shown. - FY2023-Q2Investment securities balance increases; valuation loss recognizedAnnual report
「The main factors were a ¥69.284 million increase in investment securities and a ¥513.195 million decrease in cash and deposits."Investment securities impairment loss 49,325"」
The balance of investment securities increased by ¥69.284 million from the end of the previous fiscal year to ¥585.348 million, while an impairment loss on investment securities of ¥49.325 million was recognized for the cumulative second quarter. - FY2023-Q1Quarterly increase in investment securities balanceAnnual report
「Investment securities 516.063 561.418」
The balance of investment securities increased by ¥45.355 million from ¥516.063 million at the end of the previous consolidated fiscal year to ¥561.418 million at the end of the first quarter. - FY2022-Q3Quarterly increase in investment securities balanceAnnual report
「Investment securities 436.487 456.189」
The balance of investment securities increased by ¥19.702 million from ¥436.487 million at the end of the previous consolidated fiscal year to ¥456.189 million at the end of the third quarter. - FY2022-Q2Slight quarterly decrease in investment securities balanceAnnual report
「Investment securities 436.487 435.792」
The balance of investment securities decreased by ¥0.695 million from ¥436.487 million at the end of the previous consolidated fiscal year to ¥435.792 million at the end of the second quarter. - FY2022-Q1Quarterly increase in investment securities balanceAnnual report
「Investment securities 436.487 438.575」
The balance of investment securities increased by ¥2.088 million from ¥436.487 million at the end of the previous fiscal year to ¥438.575 million at the end of the first quarter. No new impairment loss was disclosed for the current quarter. - FY2021WorsenedAnnual report
「The Group has actively made net investments, primarily overseas, from the previous fiscal year through the current fiscal year, with amounts recorded on the consolidated balance sheet of ¥464.194 million at the end of the previous fiscal year and ¥436.487 million at the end of the current fiscal year. The Group aims to generate synergies and returns from the future growth of its investee companies, but recorded an impairment loss on investment securities of ¥48.330 million as an extraordinary loss during the current fiscal year.」
The balance of investment securities decreased from the end of the previous fiscal year to ¥436.487 million, while the impairment loss for the current fiscal year amounted to ¥48.330 million. The company also states that further impairment losses may arise. - FY2021-Q3Increase in Investment SecuritiesAnnual report
「Investment securities 464.194 468.481」
The balance of investment securities increased by ¥4.287 million from ¥464.194 million at the end of the previous consolidated fiscal year to ¥468.481 million at the end of the third quarter. - FY2021-Q2Increase in Investment SecuritiesAnnual report
「Investment securities 464.194 469.576」
The balance of investment securities increased by ¥5.382 million from ¥464.194 million at the end of March 2020 to ¥469.576 million at the end of September 2020. During the six months ended, a ¥10 million payment for the acquisition of shares of an affiliated company was also recorded. - FY2021-Q1Quarterly increase in investment securities balanceAnnual report
「Investment securities 464.194 477.479」
The balance of investment securities increased by ¥13.285 million from ¥464.194 million at the end of the previous consolidated fiscal year to ¥477.479 million at the end of the first quarter. - FY2020Update to full-year investment balance and impairment lossAnnual report
「The main factors were a ¥603.978 million decrease in cash and deposits and increases of ¥252.586 million in accounts receivable, ¥164.768 million in investment securities and ¥55.020 million in shares of affiliated companies, among others.」
The balance of investment securities increased by ¥164.768 million from the end of the previous fiscal year to ¥464.194 million, and an impairment loss on investment securities of ¥22.500 million was also recorded during the current fiscal year. - FY2020-Q3Update to increase in investment securities balanceAnnual report
「The main factors were decreases of ¥369.826 million in cash and deposits and ¥288.257 million in accounts receivable, together with an increase of ¥136.498 million in investment securities, among others.」
The balance of investment securities increased by ¥136.498 million from the end of the previous consolidated fiscal year, exceeding the previously disclosed increase of ¥131.513 million. An impairment loss on investment securities of ¥22.500 million was also recorded for the nine months ended. - FY2020-Q2First statedAnnual report
「The main factor was an increase of ¥131.513 million in investment securities, among others." "This was attributable to payments of ¥138.786 million for the acquisition of investment securities, among others." "Extraordinary loss: impairment loss on investment securities ¥22.500 million"」
During the six months ended, the company acquired investment securities, increasing the balance of investment securities by ¥131.513 million, while recording an impairment loss on investment securities of ¥22.500 million.